Who owns Nextcure Inc?
- Ticker: NXTC
- CUSIP Number: 65343e108
Tip: Access positions for across all investors
Analyze quarterly positions in Nextcure with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Nextcure stock
Who bought or sold Nextcure Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Sofinnova Ventures | 2.7M | $6.0M | 0% | Mar 2024 |
|
Logos Global Management | 1.9M | $4.3M | 100% | Mar 2024 |
|
OrbiMed Advisors | 1.1M | $2.5M | -58% | Mar 2024 |
|
Millennium Management | 1.1M | $2.5M | -1% | Mar 2024 |
|
Vanguard Group | 987k | $2.2M | 9% | Mar 2024 |
|
BlackRock | 761k | $1.7M | -15% | Mar 2024 |
|
Cable Car Capital | 616k | $1.4M | 0% | Mar 2024 |
|
Long Focus Capital Management | 556k | $1.2M | 0% | Mar 2024 |
|
Acadian Asset Management | 488k | $1.1M | 0% | Mar 2024 |
|
Assenagon Asset Management | 427k | $952k | 100% | Mar 2024 |
|
Morgan Stanley | 402k | $805k | 40225700% | Mar 2024 |
|
Schonfeld Strategic Advisors | 393k | $877k | 100% | Mar 2024 |
|
Federated Investors | 328k | $374k | -11% | Dec 2023 |
|
Acuitas Investments | 322k | $717k | -14% | Mar 2024 |
|
BML Capital Management | 307k | $683k | 0% | Mar 2024 |
|
Citadel Advisors | 246k | $547k | -35% | Mar 2024 |
|
Hudson Bay Capital Management | 204k | $455k | 100% | Mar 2024 |
|
Geode Capital Management | 175k | $390k | 0% | Mar 2024 |
|
Tang Capital Management | 145k | $322k | -69% | Mar 2024 |
|
Sio Capital Management | 130k | $290k | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 86k | $192k | 0% | Mar 2024 |
|
Bridgeway Capital Management | 71k | $157k | -25% | Mar 2024 |
|
Barclays | 68k | $150k | 0% | Mar 2024 |
|
Marquette Asset Management | 58k | $130k | 0% | Mar 2024 |
|
Two Sigma Advisers | 58k | $129k | 0% | Mar 2024 |
|
ADAR1 Capital Management | 43k | $96k | -29% | Mar 2024 |
|
Ieq Capital | 37k | $83k | 0% | Mar 2024 |
|
Northern Trust | 34k | $75k | -22% | Mar 2024 |
|
LPL Financial | 27k | $60k | 100% | Mar 2024 |
|
XTX Topco | 20k | $44k | 100% | Mar 2024 |
|
Hsbc Holdings | 17k | $20k | 0% | Dec 2023 |
|
UBS Group | 11k | $24k | 73% | Mar 2024 |
|
Susquehanna International | 11k | $23k | -74% | Mar 2024 |
|
Charles Schwab Investment Management | 10k | $22k | 0% | Mar 2024 |
|
Bank of America Corporation | 2.7k | $6.1k | 10804% | Mar 2024 |
|
Tower Research Capital | 2.3k | $5.1k | -68% | Mar 2024 |
|
Wells Fargo & Company | 2.2k | $4.8k | 1292% | Mar 2024 |
|
Jpmorgan Chase & Co | 803.00 | $1.8k | -47% | Mar 2024 |
|
Rhumbline Advisers | 703.00 | $1.6k | 0% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 385.00 | $859.012000 | 0% | Mar 2024 |
|
Qube Research & Technologies | 48.00 | $107.001600 | 0% | Mar 2024 |
|
Royal Bank of Canada | 17.00 | $0 | -94% | Mar 2024 |
|
Who sold out of Nextcure?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Dec 2023 | 27k | $30k |
ExodusPoint Capital Management | Sep 2023 | 20k | $26k |
Franklin Resources | Dec 2023 | 20k | $22k |
FMR | Sep 2023 | 4.6k | $6.0k |